Investigation over Buyout for Investors in Shares of Dimension Therapeutics Inc (NASDAQ:DMTX)
An investigation was announced for investors, who currently hold shares of Dimension Therapeutics Inc (NASDAQ:DMTX), concerning the takeover of Dimension Therapeutics Inc by REGENXBIO Inc for a value of approximately $3.41 per share.
View full press release